This inventor holds 6 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovative Mind of Vishweshwaraiah Baligar
Introduction
Vishweshwaraiah Baligar, an accomplished inventor based in Bengaluru, India, is renowned for his contributions to pharmaceutical research and innovation. With a remarkable portfolio that includes three patents, Baligar has made significant strides in the field of receptor agonists, showcasing his commitment to advancing medical treatments.
Latest Patents
Among his latest inventions are the patents related to Phenylpyrrolidinone formyl peptide 2 receptor agonists. These patents disclose compounds of Formulae (I)-(IX), which act as agonists for both formyl peptide 2 (FPR2) and formyl peptide 1 (FPR1) receptors. The significance of these compounds lies in their potential applications for treating various ailments, including atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and other related diseases. Baligar's innovative work in this area highlights the importance of receptor modulation in developing new therapeutic strategies.
Career Highlights
Vishweshwaraiah Baligar is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical firm. His tenure at the company has been marked by his dedication to research and development, contributing to groundbreaking innovations that aim to improve patient outcomes in critical areas of health.
Collaborations
Throughout his career, Baligar has collaborated with several talented individuals, including Pravin Sudhakar Shirude and Balaji Seshadri. These collaborations reflect a commitment to working within a team to push the boundaries of pharmaceutical research and deliver innovative solutions to pressing health issues.
Conclusion
Vishweshwaraiah Baligar's work exemplifies the spirit of innovation within the pharmaceutical industry. His patents on Phenylpyrrolidinone formyl peptide 2 receptor agonists not only demonstrate his inventive capabilities but also hold promise for improving therapies for chronic diseases. As an influential figure in his field, Baligar continues to pave the way for advancements in medical science, making a lasting impact on patient health and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile